Nanocatalytic medicine: pathological chemical microenvironments as regulation targets for fundamental solutions of major chronic diseases
Clicks: 1
ID: 325562
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #252 of 267 articles by views in national science review
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 267 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Major chronic diseases, including cancer, cardiovascular and neurodegenerative disorders, diabetes, and non-infectious inflammations, are fundamentally driven by dysregulated pathological chemical microenvironments characterized by oxidative stress, hypoxia, acidosis, protein misfolding, and abnormal carbohydrate and lipid metabolism. These aberrant chemical milieus not only drive pathogenesis but also create a pathological ‘soil’ that supports disease progression and confers therapeutic resistance. Traditional strategies predominantly target cellular components, overlooking this fundamental chemical basis. Nanocatalytic medicine has recently emerged as a novel paradigm that directly targets these pathological chemical microenvironments through controlled in-situ catalytic reactions. Rationally designed nanocatalysts enable precise regulation of disease-associated chemicals, including generating cytotoxic reactive oxygen species for tumor therapy, scavenging excessive oxidants to alleviate inflammatory damage, catalyzing oxygen production to relieve hypoxia, and treating biomolecular aggregates in neurodegenerative diseases. This Review delineates the chemical hallmarks of major diseases, elucidates nanocatalytic strategies for their regulation, and proposes design principles for optimizing nanocatalytic medicines. By positioning pathological chemical microenvironments as fundamental therapeutic targets, nanocatalytic medicine offers an innovative and powerful chemical toolbox for treating major chronic diseases.
| Reference Key |
openalex_W7203767603
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bowen Yang, Jianlin Shi |
| Journal | national science review |
| Year | 2026 |
| DOI |
10.1093/nsr/nwag510
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.